Mckesson Medical-Surgical Inc. Corporate Office recalls Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent a
Recalled August 17, 2022 · FDA recall D-1324-2022 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
CGMP Deviations: products were stored outside the drug label specifications. · FDA Class II
Units
1 box
Sold at
Nationwide in the USA.
Description
CGMP Deviations: products were stored outside the drug label specifications.
Product
Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →